Stock A200230 TELCON RF PHARMACEUTICAL. INC.
Add to a list
To use this feature you must be a member
Log inSign up

Financials TELCON RF PHARMACEUTICAL. Inc.

Equities

A200230

KR7200230001

Communications & Networking

End-of-day quote Korea S.E.
Other stock markets
 06:00:00 2024-04-29 pm EDT 		5-day change 1st Jan Change
775 KRW -1.02% Intraday chart for TELCON RF PHARMACEUTICAL. Inc. +4.59% -11.23%
Apr. 19 TELCON RF PHARMACEUTICAL. Inc. announced that it has received KRW 22 billion in funding from Sangsangin Savings Bank, Sangsangin Plus Savings Bank Co.,Ltd. CI
Apr. 19 Abion Inc. announced that it has received KRW 19 billion in funding from TELCON RF PHARMACEUTICAL. Inc., Sangsangin Plus Savings Bank Co.,Ltd., Sangsangin Savings Bank CI

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 681,693 404,261 517,387 255,964 110,233 97,673
Enterprise Value (EV) 1 693,486 400,545 580,973 288,705 130,775 114,577
P/E ratio -46.4 x -7.35 x -12 x -11.1 x -2.56 x 8.48 x
Yield - - - - - -
Capitalization / Revenue 11.8 x 7.7 x 15.6 x 6.76 x 3.96 x 2.69 x
EV / Revenue 12 x 7.63 x 17.5 x 7.63 x 4.7 x 3.16 x
EV / EBITDA -132 x 53.3 x 252 x -795 x 599 x 22 x
EV / FCF -76.7 x 196 x -562 x -37.4 x 414 x -21.5 x
FCF Yield -1.3% 0.51% -0.18% -2.67% 0.24% -4.64%
Price to Book 4.43 x - 5.81 x 2.74 x 1.31 x 0.96 x
Nbr of stocks (in thousands) 82,330 83,181 85,377 87,509 108,604 111,881
Reference price 2 8,280 4,860 6,060 2,925 1,015 873.0
Announcement Date 3/20/19 3/22/21 3/22/21 3/22/22 3/21/23 3/19/24
1KRW in Million2KRW
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 57,708 52,478 33,141 37,841 27,830 36,307
EBITDA 1 -5,244 7,510 2,307 -363.1 218.5 5,210
EBIT 1 -9,360 3,078 -2,090 -4,563 -4,063 965.3
Operating Margin -16.22% 5.86% -6.31% -12.06% -14.6% 2.66%
Earnings before Tax (EBT) 1 -15,173 -54,937 -41,652 -22,875 -42,117 13,949
Net income 1 -13,755 -54,810 -40,893 -23,098 -42,084 13,906
Net margin -23.83% -104.44% -123.39% -61.04% -151.22% 38.3%
EPS 2 -178.5 -661.5 -503.2 -262.9 -397.0 103.0
Free Cash Flow 1 -9,039 2,046 -1,034 -7,715 316 -5,322
FCF margin -15.66% 3.9% -3.12% -20.39% 1.14% -14.66%
FCF Conversion (EBITDA) - 27.25% - - 144.64% -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 3/20/19 3/22/21 3/22/21 3/22/22 3/21/23 3/19/24
1KRW in Million2KRW
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 11,793 - 63,586 32,741 20,542 16,904
Net Cash position 1 - 3,716 - - - -
Leverage (Debt/EBITDA) -2.249 x - 27.56 x -90.18 x 94.02 x 3.245 x
Free Cash Flow 1 -9,039 2,046 -1,034 -7,715 316 -5,322
ROE (net income / shareholders' equity) -10.5% -40.9% -40.7% -23.1% -44.2% 14.8%
ROA (Net income/ Total Assets) -2.99% 1.24% -0.83% -1.62% -1.77% 0.46%
Assets 1 460,174 -4,434,807 4,923,884 1,429,866 2,380,606 2,993,200
Book Value Per Share 2 1,871 - 1,044 1,067 775.0 912.0
Cash Flow per Share 2 87.90 - 280.0 232.0 89.60 74.40
Capex 1 2,647 957 1,132 2,254 819 3,820
Capex / Sales 4.59% 1.82% 3.42% 5.96% 2.94% 10.52%
Announcement Date 3/20/19 3/22/21 3/22/21 3/22/22 3/21/23 3/19/24
1KRW in Million2KRW
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Other Communications & Networking

1st Jan change Capi.
TELCON RF PHARMACEUTICAL. INC. Stock TELCON RF PHARMACEUTICAL. Inc.
-11.23% 63.68M
CISCO SYSTEMS, INC. Stock Cisco Systems, Inc.
-6.76% 193B
ARISTA NETWORKS, INC. Stock Arista Networks, Inc.
+10.49% 82.63B
FOXCONN INDUSTRIAL INTERNET CO., LTD. Stock Foxconn Industrial Internet Co., Ltd.
+62.04% 67.28B
MOTOROLA SOLUTIONS, INC. Stock Motorola Solutions, Inc.
+9.13% 57.93B
GARMIN LTD. Stock Garmin Ltd.
+12.72% 27.89B
NOKIA OYJ Stock Nokia Oyj
+11.78% 20.39B
ZHONGJI INNOLIGHT CO., LTD. Stock Zhongji Innolight Co., Ltd.
+65.01% 20.39B
ZTE CORPORATION Stock ZTE Corporation
+8.27% 17.71B
ERICSSON Stock ERICSSON
-10.92% 17.23B
Other Communications & Networking
  1. Stock Market
  2. Equities
  3. A200230 Stock
  4. Financials TELCON RF PHARMACEUTICAL. Inc.